advice and support. This includes advice to quit smoking, take adequate physical exercise, eat healthily, aim for an optimal bodyweight, and limit the consumption of alcohol. Drug therapy, such as blood pressure-lowering and cholesterollowering drugs, is recommended for highrisk patients, depending on the levels of the risk factors (systolic pressure >140 mmHg and/or low-density lipoprotein cholesterol >2.5 mmol/l). Intermediate-risk patients may be offered drug therapy, in addition to lifestyle support. In this intermediate group drug therapy is recommended when additional risk factors are present, such as the presence of a family history of cardiovascular disease, renal impairment, lack of exercise, or obesity. The final judgement is made by the GP.
In a recent review, Chou and colleagues indicated that, out of the 63 prospective studies into the relation of electrocardiogram (ECG) abnormalities and future CV events, no studies provided evidence on how accurately ECG abnormalities classified participants into high-, intermediate-, or low-risk groups, compared with traditional risk factor assessment alone. Thus the clinical implication of a resting ECG remained undetermined. 3 Furthermore, the European Society of Cardiology (ESC) study group
Aim
To determine whether measurement of ECG abnormalities on top of established risk estimation (SCORE) improves CV risk classification in a primary care population.
Design and setting
A cohort study of patients enlisted with academic general practices in the Netherlands (the Utrecht Health Project [UHP]).
Method
Incident CV events were extracted from the GP records. MEANS algorithm was used to assess ECG abnormalities. Cox proportional hazards modelling was applied to relate ECG abnormalities to CV events. For a prediction model only with SCORE variables, and a model with SCORE+ECG abnormalities, the discriminative value (area under the receiver operator curve [AUC] ) and the net reclassification improvement (NRI) were estimated.
Results
A total of 2370 participants aged 38-74 years were included, all eligible for CV risk assessment. During a mean follow-up of 7.8 years, 172 CV events occurred. In 19% of the participants at least one ECG abnormality was found (Lausanne criteria). Presence of atrial fibrillation/flutter (AF) and myocardial infarction (MI) were significantly related to CV events. The AUC of the SCORE risk factors was 0.75 (95% CI = 0.71 to 0.79). Addition of MI or AF resulted in an AUC of 0.76 (95% CI = 0.72 to 0.79) and 0.75 (95% CI = 0.72 to 0.79), respectively. The NRI with the addition of ECG abnormalities was small (MI 1.0%; 95% CI = -3.2% to 6.9%; AF 0.5%; 95% CI = -3.5% to 3.3%).
of sports cardiology has recommended use of the Lausanne criteria to assess an individual risk on sudden cardiac event. Yet evidence on the relation with CV events and its potential role in risk classification is not established. 4 The ESC's recent CV disease prevention guidelines 5 recommend managing subjects with a low (<4%) CV mortality risk based on SCORE, but with left ventricular hypertrophy (LVH) on the ECG as individuals at intermediate risk (5-9%) for CV events. However, guidelines such as the Joint British Societies' guidelines on prevention of CV disease in clinical practice 6 and the clinical practice guideline for CV risk management in the Netherlands 7 do not recommend an ECG. In addition, ECG findings such as right and left bundle branch blocks (BBBs), ST-segment, and/or T-wave abnormalities and second-and thirddegree atrioventricular (AV) blocks have been found to consistently predict future CV events in the population at large. [8] [9] [10] These ECG findings have not been mentioned in the guidelines even though the relative risk of CV disease in these latter abnormalities is of similar magnitude to that of LVH.
Since many abnormalities found on routine resting ECGs have prognostic and potential therapeutic consequences they may be of clinical relevance. The resting ECG is easily made, low in cost, and applicable in primary care. Therefore, this study examined whether measurement of ECG abnormalities on top of established risk factor measurement (SCORE risk factors) improved CV risk classification.
METHOD

Study population
This study used data derived from the Utrecht Health Project (UHP). This is an ongoing primary care-based cohort study among patients enlisted with academic general practice centres affiliated with the Julius Center, University Medical Center Utrecht, the Netherlands. Patients from a newly-developed residential area, near the city of Utrecht, were invited to come in for an 'individual health profile' (IHP). The study was described more extensively elsewhere. 11 Inclusion of participants in the UHP started in 2000. ECGs were collected from 6526 subsequent participants recruited from April 2000 to January 2007.
The present analysis was restricted to those participants eligible for SCORE estimation according to the Dutch guideline. 1 Participants with already established CV disease at inclusion were excluded (n = 192). Those aged <38 years and ≥73 years were excluded (n = 3605). Participants with a systolic blood pressure >180 mmHg (n = 50) and with a cholesterol ratio >8 (n = 226) were excluded. Of the remaining 2453 participants complete information on both SCORE risk factors and ECG parameters was available for 2370 (96.6%), who constitute the current study population. Considering the low percentage of missing data no attempt was made to impute missing values.
Risk factor measurements
All participants went through a general health questionnaire with a trained nurse, and information was obtained on medical history, current drug use, and lifestyle. Height and weight were measured. Serum cholesterol and serum glucose were measured on a Synchron LX20 (Beckman Coulter). Blood pressure was measured on the dominant arm with an Omron M4 device. The cuff sizes were adjusted to the arm circumference. Blood pressure measurements were taken twice in the sitting position, with a 2-minute gap, on a single occasion. The mean of both measurements was used for risk estimation. Using the SCORE algorithm, each individual was categorised into a risk category based on the individual's age, sex, cigarette smoking status, systolic blood pressure, and TC/HDL ratio. The estimated 10-year CV risk groups were low (<10%), intermediate (10-19%) , or high (≥20%).
1,2
ECG measurements
The 12-lead ECG, taken in the resting condition, was digitally stored and analysed by the Modular ECG Analysis System (MEANS), as described in detail elsewhere. 12 MEANS is a scoring system that can be used by a GP resulting in a diagnosis. Measurements were derived from the representative complex that results from selective averaging of dominant beats. The
How this fits in
It has long been known that electrocardiogram (ECG) abnormalities are significantly associated with increased risk of cardiovascular (CV) disease. The ECG is easily performed, low in cost, and applicable in primary care, and therefore may be of use for prediction of CV risk. This study showed however that adding ECG information to SCORE information (age, sex, smoking, systolic blood pressure, and total cholesterol/HDL ratio) does not improve risk classification. measurement and classification parts of MEANS have been extensively evaluated, both by the developers themselves and by independent observers. 13 Based on the MEANS classification, abnormalities were classified into myocardial infarction (MI), LVH, AF, left and right BBBs, ST-segment and/or T-wave abnormalities, and secondand third-degree AV blocks. A previous study showed that sensitivity and specificity for having the diagnosis correct is similar when using the MEANS scoring system or having the diagnosis set by a cardiologist. 14 However, another study has reported less specificity. 15 In addition to the MEANS classification, all ECG patterns were evaluated according to the Lausanne criteria for ECG evaluation, as recommended by the ESC (Appendix 1). 16 
Cardiovascular events
In April 2012 incident CV events since baseline were assessed. Newly-diagnosed CV diseases were identified using the International Classification of Primary Care (ICPC) codes in the GP records. 17, 18 A CV event was defined as the occurrence of MI (K75), angina pectoris (K74), stroke (K90), transient ischaemic attack (K89), atherosclerosis (K91), heart failure (K77), aortic aneurysm (K99.1), peripheral arterial disease (K92.1), or vascular dementia (P70.2) during follow-up. For participants who died during follow-up, it was determined if the cause of death had been of CV origin.
Statistical analysis
For every individual the 10-year CV risk was calculated according to the SCORE risk classification and individuals were classified into risk categories of low (<10%), intermediate (10-20%), or high (≥20%). 1, 2 General characteristics were presented as proportions or means with corresponding standard deviations, when appropriate. Data were presented for the total group and by risk category. The ECG abnormalities were evaluated using Cox proportional hazard models. Each ECG abnormality was evaluated separately. Those ECG abnormalities that were related to CV events in the Cox model with a P-value <0.157 were combined in a more extended multivariable Cox model, including the SCORE variables.
The area under the operating curve and the net reclassification improvement. The original variables of SCORE -age (adapted in the presence of diabetes mellitus and/or rheumatoid arthritis), sex, smoking status, systolic blood pressure, and cholesterol/HDL ratio -were refitted using a multivariable Cox proportionalhazards model. This baseline model was extended by those ECG abnormalities that were related to CV events in the Cox model with a P-value <0.157. The discriminative value of both models was expressed with the area under the receiver operator curve (AUC). The 10-year absolute risk to develop e3 British Journal of General Practice, January 2015 [18] [19] [20] was calculated. The NRI quantifies the percentage of correct movement across categories for those with and without events. Correct movement is upward classification by a new marker in those with events and downward classification in those without events. This study's risk prediction model was based on time-to-event data, which contain not only events and nonevents but also individuals who discontinue prematurely. Therefore, the number of individuals reclassified due to a change in risk category was then described using the NRI taking survival time into account. The corresponding 95% confidence intervals (CIs) were obtained with bootstrapping. SPSS (version 20) was used for the statistical calculations. All NRI analyses were performed in the statistical environment R (version 2.10.0). The model was not validated with ECG measurements because the aim was not to create and validate a new prediction rule, but to assess the actual improvement in risk prediction. All statistical testing was two-sided and P<0.05 was considered statistically significant.
RESULTS
The study population comprised 2370 participants. Of all participants, 81% had a low risk and 9.7% had an intermediate risk; 9.3% was considered high risk ( Table 1 ). The mean follow-up was 7.8 years during which 172 new CV events occurred. The incidence of CV events ranged from 4.6% in the lowrisk group, to 15.2% in the intermediate group, up to 22.3% in the high-risk group (Table 1) . In general, the prevalence of single ECG abnormalities was low except for prolongation of heart rate-corrected QT interval (7.3%), whereas the prevalence of an abnormal ECG based on the presence of any of the Lausanne criteria was high (19.0%) ( Table 2) .
Of all the ECG abnormalities evaluated, atrial fibrillation/flutter (AF), and MI were statistically significant related to CV events after adjustment for SCORE risk factors British Journal of General Practice, January 2015 e4 ( Table 3) . A positive Lausanne score was not significantly related to CV event risk (1.2; 95% CI = 0.8 to 1.6). Based on this analysis it was possible to predict CV events using only the SCORE risk factors with an AUC of 0.75 (95% CI = 0.71 to 0.79). Addition of the information on the presence of MI or the presence of AF resulted in an AUC of 0.76 (95% CI = 0.72 to 0.79) and 0.75 (95% CI = 0.72 to 0.79), respectively. As the Lausanne score was not related to event risk, the AUC for the Lausanne criteria was not assessed.
This analysis of reclassification improvement showed a small increase of the NRI for SCORE plus MI of 1.0% (95% CI = -3.2% to 6.9%). The NRI for SCORE plus AF was 0.5% (95% CI = -3.5% to 3.3%). Both results indicated no significant improvement of the model with ECG abnormalities.
DISCUSSION Summary
This study's results show that, in the general population with a mean age of 48 years and from whom information on established risk factors is available, there is no added value in performing a resting ECG to improve CV risk classification. More specifically, the Lausanne criteria evaluation, the presence of a MI, and the presence of AF did not improve the risk classification.
Strengths and limitations
Most studies on ECG abnormalities used manual readings from printed ECGs and/ or applied the Minnesota Codes for the ECG diagnoses, although specificity has been shown to be less favourable. A less effective performance may lead to an underestimation of the relations under study, and may explain the small magnitude of the NRI. Therefore confirmation of these results in a larger sample of the population is needed. In addition, the number of events was reasonably high for the overall evaluation, but too small for detailed, valid, and precise subgroup analyses (for example, by sex or by SCORE risk category).
Comparison with existing literature
At present, as indicated by the most recent review, there is no evidence that assesses the degree to which performing resting ECG in an individual participant more accurately moves them from one risk category to another. 3 Two studies have reported on the change in the AUC. 19, 20 These studies showed slight improvements in AUC, of a similar magnitude as in the current study. Yet the change in the AUC is of limited clinical usefulness. It does not provide information about the actual predicted risks, or the proportion of participants classified (or reclassified) as high, intermediate, or low risk. 21 This study expands the current evidence by showing that the NRI was small, not statistically significant, and most likely of limited clinical value.
The currently available studies are mainly directed towards assessing the relation e5 British Journal of General Practice, January 2015 between ECG abnormalities and risk of future events. It has been consistently shown that abnormalities on a resting ECG (such as ST-segment or T-wave abnormalities, AF, LVH, BBB, left axis deviation, or Q-waves) are associated with increased risk of subsequent CV events with relative risk estimates ranging from 1.4 to 2.1. This study confirmed that for some of these parameters. The evidence was expanded by showing that an assessment of the ECG using the Lausanne criteria was not related to event risk. The importance of this finding is in the fact that these criteria were set up to identify individuals at high risk of a cardiac event.
15
Implications for practice These results suggest that there is no use in performing an ECG for improvement of risk classification. The findings are in line with several guidelines that recommend refraining from a routine resting ECG for CV risk stratification. 5, 6 In the November 2013 guideline on the assessment of CV risk, issued by the American Heart Association in collaboration with the American College of Cardiology, an ECG is not recommended in risk assessment. However, this guideline does indicate that an ECG may be of value when it is meant for diagnostic purposes. 22 The latter is an important addition, since one of the reasons for an ECG may be the detection of conditions (that is, diagnosis) that require different treatment options than in increased CV risk assessment. In the study population, a reasonable number of unrecognised MIs were found (2.0%). AF was found in 0.6%, whereas changes in repolarisation were observed in 3.1%. Yet this is not the topic of current analyses. For a formal recommendation of the diagnostic yield, a different approach is needed in which balancing prevalence of the condition, number needed to screen to detect one case, options for treatment, and costs need to be discussed. Indeed a previous report, from the current study's group, supported an ECG measurement in individuals with hypertension, as the prevalence of abnormalities was higher than in the non-hypertensive population and thus the number needed to screen was acceptably low, with a potential to prevent future CV events that was relatively high. 23 In conclusion, performing a resting ECG does not improve CV risk classification when information on age, sex, smoking, systolic blood pressure, and TC/HDL ratio is already available.
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